Large-scale testing (Phase 3)Study completedNCT00036556What this trial is testingStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerWho this might be right forProstatic Neoplasms Abbott 941
Not applicableStudy completedNCT01062503What this trial is testingDuration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPCWho this might be right forMetastatic Prostate CancerBone Metastasis University Health Network, Toronto 48
Testing effectiveness (Phase 2)WithdrawnNCT01087580What this trial is testingDocetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate CancerWho this might be right forPROSTATE CANCER Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT02906605What this trial is testingThe Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT01487720What this trial is testingGEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Asan Medical Center 33
Early research (Phase 1)Study completedNCT04428788What this trial is testingStudy to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstatic Neoplasms Celgene 131
Testing effectiveness (Phase 2)Study completedNCT01075308What this trial is testingSB939 in Treating Patients With Recurrent or Metastatic Prostate CancerWho this might be right forProstate Cancer NCIC Clinical Trials Group 32
Early research (Phase 1)Study completedNCT02262910What this trial is testingStudy of ES414 in Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Aptevo Therapeutics 35
Early research (Phase 1)Ended earlyNCT05252390What this trial is testingNUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorOvarian CancerOvary Cancer+24 more Nuvation Bio Inc. 82
Large-scale testing (Phase 3)Study completedNCT00744497What this trial is testingRandomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms Bristol-Myers Squibb 1,930
Testing effectiveness (Phase 2)Active Not RecruitingNCT05502315What this trial is testingStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate CancerWho this might be right forCastration-resistant Prostate CancerMetastatic Cancer Rana McKay, MD 47
Not applicableNot Yet RecruitingNCT07697989What this trial is testingPluvicto Real-world Investigation in Survival in Metastatic CRPCWho this might be right forProstatic Neoplasms, Castration-ResistantNeoplasm Metastasis Novartis Pharmaceuticals 1,085
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663997What this trial is testing177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate CancerWho this might be right forProstate Cancer Canadian Cancer Trials Group 200
Not applicableLooking for participantsNCT07691697What this trial is testingPSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate CancerWho this might be right forOligoprogressive Prostate CancerMetastatic Prostate Cancer Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06615752What this trial is testingGreen Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer PatientsWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC) Charles Drew University of Medicine and Science 99
Early research (Phase 1)Study completedNCT01144897What this trial is testingPET Acetate for Castrate-Resistant Prostate Cancer on ChemotherapyWho this might be right forCastrate Resistant Prostate CancerProstate Cancer Daniel Vaena 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340374What this trial is testingCabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate CancermCRPC Peter MacCallum Cancer Centre, Australia 35
Testing effectiveness (Phase 2)Study completedNCT00770848What this trial is testingAMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate CancerWho this might be right forCancerCastrate-Resistant Prostate CancerMestastatic Prostate Cancer+1 more Amgen 162
Early research (Phase 1)Looking for participantsNCT05997615What this trial is testingSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerWho this might be right forHormone-refractory Prostate Cancer Astellas Pharma Global Development, Inc. 437
Not applicableStudy completedNCT01560858What this trial is testingTreatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateWho this might be right forProstate Cancer Ipsen 407